Mary Kerr
Chief Executive Officer bij NeRRe Therapeutics Ltd.
Vermogen: 46 732 $ op 29-02-2024
Profiel
Founder of KaNDy Therapeutics Ltd., Mary Kerr currently is Chief Executive Officer & Director at NeRRe Therapeutics Ltd.
Dr. Kerr is also on the board of NeRRe Therapeutics Holdings Ltd.
In the past she occupied the position of Chief Executive Officer & Director at KaNDy Therapeutics Ltd., Senior Vice President for Global Franchise Group LLC and Member of ViiV Healthcare Ltd.
She received a doctorate from the University of Bradford and an MBA from Kingston University.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
GALAPAGOS NV
0.00% | 15-03-2023 | 1 313 ( 0.00% ) | 46 732 $ | 29-02-2024 |
Actieve functies van Mary Kerr
Bedrijven | Functie | Begin |
---|---|---|
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Chief Executive Officer | 01-09-2015 |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Director/Board Member | 08-09-2017 |
Eerdere bekende functies van Mary Kerr
Bedrijven | Functie | Einde |
---|---|---|
GALAPAGOS NV | Director/Board Member | 18-09-2023 |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Founder | 01-09-2020 |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Corporate Officer/Principal | - |
Global Franchise Group LLC
Global Franchise Group LLC Food RetailRetail Trade Global Franchise Group LLC operates as a strategic brand management company with a focus on franchising. It specializes in franchising restaurant industries. The company was founded in 2010 and is headquartered in Atlanta, GA. | Corporate Officer/Principal | - |
Opleiding van Mary Kerr
University of Bradford | Doctorate Degree |
Kingston University | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GALAPAGOS NV | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Global Franchise Group LLC
Global Franchise Group LLC Food RetailRetail Trade Global Franchise Group LLC operates as a strategic brand management company with a focus on franchising. It specializes in franchising restaurant industries. The company was founded in 2010 and is headquartered in Atlanta, GA. | Retail Trade |
ViiV Healthcare Ltd.
ViiV Healthcare Ltd. Pharmaceuticals: MajorHealth Technology ViiV Healthcare Ltd. manufactures and distributes pharmaceutical products. Its medicine include Triumeq, Tivicay, Selzentry, Celesentri, Epzicom, Kivexa, Ziagen, Trizivir, Combivir, Retrovir AZT, Lexiva, Telzir, Viracept and Rescriptor. The company was founded in 2009 and is headquartered in Brentford, the United Kingdom. | Health Technology |
NeRRe Therapeutics Ltd.
NeRRe Therapeutics Ltd. Medical DistributorsDistribution Services NeRRe Therapeutics Ltd. provides clinical and pre clinical drugs for treatment of neuronal hypersensitivity. It develops neurokinin receptor antagonists acquired from GlaxoSmithKline. The company was founded by Emiliangelo Ratti and Mike Trower in 2012 and is headquartered in Stevenage, the United Kingdom. | Distribution Services |
KaNDy Therapeutics Ltd.
KaNDy Therapeutics Ltd. BiotechnologyHealth Technology KaNDy Therapeutics Ltd. engages in the provision of a treatment of chronic debilitating female sex-hormone related conditions. Its product is NT-814 a non-hormonal therapy to treat moderate to severe post-menopausal vasomotor symptoms. The company was founded by Dr. Mike Trower and Mary Kerr in 2017 and is headquartered in Stevenage, the United Kingdom. | Health Technology |
NeRRe Therapeutics Holdings Ltd.
NeRRe Therapeutics Holdings Ltd. Miscellaneous Commercial ServicesCommercial Services NeRRe Therapeutics Holdings Ltd. is a British biotechnology company founded in 2017. The private company is based in Stevenage, UK. The company is engaged in research and development of biotechnology. | Commercial Services |